With offices in Philadelphia and Boston, SwanBio Therapeutics is developing leading-edge therapies to deliver dramatic clinical efficacy for the treatment of neurological diseases. We are driven by an unrelenting passion to solve difficult challenges, and a belief that meaningful discovery is borne of curiosity, collaboration, and compassion.
Founded by proven industry leaders with a commitment to positively impacting the lives of people with neurological diseases, SwanBio merges clinical, scientific and drug commercialization expertise.
To learn about career opportunities contact us at careers@swanbiotx.com.
Location: United States, Pennsylvania, Lower Merion Township
Member count: 11-50
Total raised: $108M
Founded date: 2018
Investors 1
| Date | Name | Website |
| - | Syncona Pa... | synconaltd... |
Funding Rounds 2
| Date | Series | Amount | Investors | Deal News |
| 19.05.2022 | Series B | $56M | Syncona Pa... | finsmes.co... |
| 24.04.2020 | Series A | $52M | - | finsmes.co... |
Mentions in press and media 2
| Date | Title | Description | Category | Author | Source |
| 19.05.2022 | SwanBio Th... | SwanBio Therapeutics, a Philad... | USA | - | finsmes.co... |
| 24.04.2020 | SwanBio Th... | SwanBio Therapeutics, a Bala C... | USA | - | finsmes.co... |